LF Esther, Blessy Jose, D. Maria, J. Becerra, LS Beatriz, LG Natalia, S. Ramón, AV Amaya, S. Maite, NS Lorena
{"title":"新冠肺炎时代对门诊患者的新要求:适应药学服务","authors":"LF Esther, Blessy Jose, D. Maria, J. Becerra, LS Beatriz, LG Natalia, S. Ramón, AV Amaya, S. Maite, NS Lorena","doi":"10.1136/EJHPHARM-2021-EAHPCONF.30","DOIUrl":null,"url":null,"abstract":"Background and importanceAdapt the outpatients care activity to the scenario arising out of the COVID-19 pandemic Aim and objectivesReorganisation of the area, non in-person consultation, medication home delivery (MHD) and reduce patient attendance at day hospitals Material and methodsPhase 1 (P1): reinforcement of human resources, increase and easy the presential and telepharmacy schedule, adaptation of the facilities Phase 2 (P2): advanced preparation of the medication, MHD, substitution of intravenous treatments by subcutaneous treatments The telepharmacy and MHD were conducted at patients’ request Delivery routes and alternative urgent delivery systems were established P1 activities began 2 weeks prior to the announcement of the State of Alarm (SoA, 16 March 2020) and P2 began and continues for vulnerable patients Our project is currently underway in a proactive, selective and continuous way ResultsActivities were analysed during 2020, weeks 12–19 (16 March to 10 May 2020) and compared with theoretical activity during the same period in 2019, with an increase in activity (+21%) The difference between the sum of in-person and telematic consultations and the theoretical consultations for the period was named after omitted consultations Overall activity in weeks 12–19 was 5550 consultations, of which 4414 (79 5%) were in-person and 1136 (20 5%) telematic The estimated activity would have been 7030 consultations, and 1480 (21% of the theoretical ones) have been omitted In-person activity decreased from 5973 patients between weeks 12 and 19 in 2019 to 4414 in 2020 (−23 3%) Distribution of the 1136 MHD: week 12 (30), week 13 (131), week 14 (232), week 15 (190), week 16 (168), week 17 (155), week 18 (115) and week 19 (115) Waiting times for in-person consultation were reduced from an average of 5 2 min/patient in the pre-alarm period to 3 min during the alarm (−42 3%) Conclusion and relevanceOur data may be used to detect areas for improvement;consultations should be made proactively and tools are needed to qualitatively analyse omitted activity A system is needed to account for tele-assistance that has not resulted in dispensing medication or MHD References and/or acknowledgementsConflict of interestNo conflict of interest","PeriodicalId":11991,"journal":{"name":"European Journal of Hospital Pharmacy: Science and Practice","volume":"13 6 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"2SPD-047 New requirements of outpatients in the COVID-19 era: adapting pharmaceutical care\",\"authors\":\"LF Esther, Blessy Jose, D. Maria, J. Becerra, LS Beatriz, LG Natalia, S. Ramón, AV Amaya, S. Maite, NS Lorena\",\"doi\":\"10.1136/EJHPHARM-2021-EAHPCONF.30\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background and importanceAdapt the outpatients care activity to the scenario arising out of the COVID-19 pandemic Aim and objectivesReorganisation of the area, non in-person consultation, medication home delivery (MHD) and reduce patient attendance at day hospitals Material and methodsPhase 1 (P1): reinforcement of human resources, increase and easy the presential and telepharmacy schedule, adaptation of the facilities Phase 2 (P2): advanced preparation of the medication, MHD, substitution of intravenous treatments by subcutaneous treatments The telepharmacy and MHD were conducted at patients’ request Delivery routes and alternative urgent delivery systems were established P1 activities began 2 weeks prior to the announcement of the State of Alarm (SoA, 16 March 2020) and P2 began and continues for vulnerable patients Our project is currently underway in a proactive, selective and continuous way ResultsActivities were analysed during 2020, weeks 12–19 (16 March to 10 May 2020) and compared with theoretical activity during the same period in 2019, with an increase in activity (+21%) The difference between the sum of in-person and telematic consultations and the theoretical consultations for the period was named after omitted consultations Overall activity in weeks 12–19 was 5550 consultations, of which 4414 (79 5%) were in-person and 1136 (20 5%) telematic The estimated activity would have been 7030 consultations, and 1480 (21% of the theoretical ones) have been omitted In-person activity decreased from 5973 patients between weeks 12 and 19 in 2019 to 4414 in 2020 (−23 3%) Distribution of the 1136 MHD: week 12 (30), week 13 (131), week 14 (232), week 15 (190), week 16 (168), week 17 (155), week 18 (115) and week 19 (115) Waiting times for in-person consultation were reduced from an average of 5 2 min/patient in the pre-alarm period to 3 min during the alarm (−42 3%) Conclusion and relevanceOur data may be used to detect areas for improvement;consultations should be made proactively and tools are needed to qualitatively analyse omitted activity A system is needed to account for tele-assistance that has not resulted in dispensing medication or MHD References and/or acknowledgementsConflict of interestNo conflict of interest\",\"PeriodicalId\":11991,\"journal\":{\"name\":\"European Journal of Hospital Pharmacy: Science and Practice\",\"volume\":\"13 6 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Hospital Pharmacy: Science and Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.30\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Hospital Pharmacy: Science and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.30","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
2SPD-047 New requirements of outpatients in the COVID-19 era: adapting pharmaceutical care
Background and importanceAdapt the outpatients care activity to the scenario arising out of the COVID-19 pandemic Aim and objectivesReorganisation of the area, non in-person consultation, medication home delivery (MHD) and reduce patient attendance at day hospitals Material and methodsPhase 1 (P1): reinforcement of human resources, increase and easy the presential and telepharmacy schedule, adaptation of the facilities Phase 2 (P2): advanced preparation of the medication, MHD, substitution of intravenous treatments by subcutaneous treatments The telepharmacy and MHD were conducted at patients’ request Delivery routes and alternative urgent delivery systems were established P1 activities began 2 weeks prior to the announcement of the State of Alarm (SoA, 16 March 2020) and P2 began and continues for vulnerable patients Our project is currently underway in a proactive, selective and continuous way ResultsActivities were analysed during 2020, weeks 12–19 (16 March to 10 May 2020) and compared with theoretical activity during the same period in 2019, with an increase in activity (+21%) The difference between the sum of in-person and telematic consultations and the theoretical consultations for the period was named after omitted consultations Overall activity in weeks 12–19 was 5550 consultations, of which 4414 (79 5%) were in-person and 1136 (20 5%) telematic The estimated activity would have been 7030 consultations, and 1480 (21% of the theoretical ones) have been omitted In-person activity decreased from 5973 patients between weeks 12 and 19 in 2019 to 4414 in 2020 (−23 3%) Distribution of the 1136 MHD: week 12 (30), week 13 (131), week 14 (232), week 15 (190), week 16 (168), week 17 (155), week 18 (115) and week 19 (115) Waiting times for in-person consultation were reduced from an average of 5 2 min/patient in the pre-alarm period to 3 min during the alarm (−42 3%) Conclusion and relevanceOur data may be used to detect areas for improvement;consultations should be made proactively and tools are needed to qualitatively analyse omitted activity A system is needed to account for tele-assistance that has not resulted in dispensing medication or MHD References and/or acknowledgementsConflict of interestNo conflict of interest